| Literature DB >> 3742715 |
I Mitchell, N Deshpande, R Millis, R D Rubens.
Abstract
The activity of phosphohexose isomerase [PHI] was measured in 48 primary carcinomas from patients with breast cancer, and its usefulness as a predictor of response to cytotoxic drugs at the metastatic stage was evaluated. There was a statistically significant difference in the activity of PHI between responders and non-responders to these treatments. These preliminary findings are currently being evaluated in an extended series.Entities:
Mesh:
Substances:
Year: 1986 PMID: 3742715 DOI: 10.1007/bf00256702
Source DB: PubMed Journal: Cancer Chemother Pharmacol ISSN: 0344-5704 Impact factor: 3.333